NUSATRIP Inc Notified of Nasdaq Delisting Determination

What Happened
NUSATRIP Incorporated announced in an 8‑K that on August 3, 2026 it received a Delisting Letter from The Nasdaq Stock Market LLC informing the company that Nasdaq staff has determined to delist NUSATRIP's securities. Nasdaq cited several factors, including an SEC trading suspension in October 2025 tied to potential manipulation, the company’s failure to file its Form 10‑K for the year ended December 31, 2025 and its Form 10‑Q for the quarter ended March 31, 2026, and related public interest concerns. The company says it will not appeal Nasdaq’s determination and intends to seek quotation of its common stock on the over‑the‑counter (OTC) market.

Key Details

• Delisting notice dated August 3, 2026; company must request appeal by August 10, 2026 to avoid suspension.
• If not appealed, Nasdaq trading suspension would begin at the opening of business on August 12, 2026 and a Form 25‑NSE will be filed to remove the listing.
• Nasdaq cited the company’s delinquent SEC filings (failure to file Form 10‑K for FY 2025 and Form 10‑Q for Q1 2026) and an October 2025 SEC trading suspension as bases for delisting.
• Society Pass Incorporated (SOPA) controls ~78% of voting power; SOPA and its subsidiary SoPa, Inc. filed for Chapter 11 on May 14, 2026, creating additional public‑interest concerns cited by Nasdaq.
• The company issued a press release on August 7, 2026 announcing the Delisting Letter (Exhibit 99.1).

Why It Matters
A Nasdaq delisting means NUSATRIP’s common stock may stop trading on Nasdaq and move to the OTC market, which typically reduces liquidity and can make shares harder to trade and price. The delisting stems from missed SEC filings and regulatory concerns already disclosed (including a prior SEC trading suspension) and the bankruptcy of the controlling shareholder, all facts investors should consider when evaluating liquidity, disclosure risk, and the company’s near‑term regulatory status.